Homozygous jumonji ( jmj 2 /jmj 2 ) mice were previously shown to exhibit hepatic hypoplasia and defective hematopoiesis in the liver and die at around embryonic day 15.5 (E15.5), suggesting that jmj is essential for liver development. In order to gain insight into the mechanism of liver development, we analyzed the expression and function of jmj in fetal hepatocytes. The number of hepatocytes in jmj 2 /jmj 2 mice was markedly reduced in comparison with control mice and the expression of jmj in hepatocytes increased along with development. As jmj 2 /jmj 2 embryos die by E15.5, we employed an in vitro culture system in which fetal hepatocytes differentiate in response to oncostatin M. The proliferation potential of jmj 2 /jmj 2 hepatocytes was comparable to that of wild type cells in vitro, however maturation of hepatocytes as evidenced by the expression of liver enzymes such as tyrosine amino transferase was severely impaired by the jmj gene inactivation. These results suggested that jmj plays a pivotal role in the development of mid-fetal hepatocytes to the neonatal stage. q
Introduction
During embryonic development, the liver bud is formed from the foregut endoderm. At embryonic day 8.5 (E8.5) in the mouse, the foregut endoderm commits to hepatic cells in response to signals from the cardiac mesoderm, leading to the expression of hepatocyte-specific genes, albumin and afetoprotein (Gualdi et al., 1996) . Previous reports showed that bone morphogenic protein (BMP) derived from the septum transversum mesenchyme and fibroblast growth factors (FGFs) 1 and 2 derived from the cardiac mesoderm are required for the induction of hepatogenesis (Rossi et al., 2001; Jung et al., 1999) and that proliferation of hepatocytes in the liver bud is stimulated by endothelial cells (Matsumoto et al., 2001) . At around E11, hematopoietic stem cells and progenitor cells derived from the yolk sac and the aorta-gonad-mesonephros (AGM) region colonize the liver (Müller et al., 1994; Medvinsky and Dzierzak, 1996) and the liver functions as the major site of hematopoiesis in the embryo until the neonatal stage (Dzierzak et al., 1998; Ema and Nakauchi, 2000) . While the embryonic liver lacks most of the liver functions as a center of metabolism in the adult, the liver acquires those functions during the perinatal and postnatal stages (Zaret, 1998) . However, the mechanism underlying the control of proliferation and differentiation of the fetal hepatic cells remains largely unknown.
Gene inactivation studies in mice have identified a number of genes that are involved in early liver development. For example, disruption of the mouse Hex gene, a transcription factor with a homeo domain, results in embryonic death at around E10.5 and exhibits defects in hepatic differentiation (Keng et al., 2000) , indicating that Hex is essential for the earliest stage of liver development. Although mice deficient in both H-Ras and N-Ras develop normally, K-Ras-deficient mice exhibit defects in multiple organs including the liver and heart and die between embryonic day 12 and term (Koera et al., 1997; Johnson et al., 1997) . It was reported that K-Ras-deficient mice are anemic and their livers are small and accumulate dead hepatic cells. Homozygous inactivation of either one of Rel-A, IKK-b and IKK-g (NEMO), main components of the NF-kB signal pathway, causes extensive apoptosis of hepatocytes in the mid-fetal liver (Beg et al., 1995; Tanaka et al., 1999; Rudolph et al., 2000) . In addition, c-jun knockout mice die between E11.5 and E15.5 and exhibit defective liver development (Hilberg et al., 1993; Johnson et al., 1993) . The c-jun-deficient livers appear hypoplastic and contain scattered hepatocytes with features of apoptosis and necrosis (Hilberg et al., 1993; Johnson et al., 1993) . Moreover, SEK1 homozygous mutant embryos also exhibit severe impairment in hepatogenesis and liver formation and mutant hepatocytes displayed features of apoptosis at E12.5 (Ganiatsas et al., 1998; Nishina et al., 1999) . These results indicated that these genes are crucial for the survival of hepatocytes. However, as those mice are embryonically lethal, the roles of the genes essential for liver development await further investigation.
The jumonji ( jmj) gene is one such gene required for liver development. The jmj gene was originally identified by the gene trap strategy (Takeuchi et al., 1995) and encodes a protein that is partially homologous to the AT-rich interaction domain (ARID) of the DNA binding proteins such as Dead Ringer in Drosophila, Bright in mouse and SWI1 in yeast (Gregory et al., 1996; Herrscher et al., 1995; Peterson and Herskowitz, 1992; Takeuchi, 1997; Balciunas and Ronne, 2000) . While heterozygous ( jmj þ /jmj 2 ) embryos show no apparent abnormalities in the BALB/cA background, almost all jmj 2 /jmj 2 embryos die by E15.5 with edema and exhibit various abnormalities of the fetal liver. In the liver, extensive cell death was observed in regions proximal to the liver capsule (Motoyama et al., 1997) , and definitive hematopoiesis was reduced and the number of total cells in the liver also decreased (Kitajima et al., 1999) . In contrast, the number of colony forming unit megakaryocytes (CFU-meg) was higher in the fetal liver of jmj 2 /jmj 2 than that of wild-type (Kitajima et al., 2001 ) and jmj was strongly expressed in megakaryocytes in the midfetal liver (Motoyama et al., 1997) . Interestingly, overexpression of jmj cDNA in COS-7 and NIH3T3 cells reduced cell proliferation, indicating that the jmj protein participates in the negative regulation of cell proliferation (Toyoda et al., 2000) . Therefore, the abnormal growth of megakaryocytes in the fetal liver is likely due to the lack of jmj expression in jmj 2 /jmj 2 megakaryocytes (Kitajima et al., 2001 ). However, as jmj 2 /jmj 2 embryos die by E15.5, it was not possible to examine the development of mutant hepatocytes after the mid-fetal stage in vivo.
We previously established a primary culture system of hepatic cells derived from the mouse fetal liver at E14.5, in which oncostatin M (OSM), an Interleukin (IL)-6 family cytokine, in the presence of glucocorticoid promotes hepatic maturation in vitro Kinoshita et al., 1999) . OSM induces the expression of glucose-6-phosphatase (G6Pase) and tyrosine aminotransferase (TAT), accumulation of glycogen and lipids and the clearance of ammonia Kojima et al., 2000) . In addition, high cell density culture also induced hepatic maturation in our fetal hepatic culture . Recently, we showed that EHS (extracellular matrices derived from Engelbreth-Holm-Swarm cells) in combination with OSM further advances the differentiation of fetal hepatocytes, leading to the expression of tryptophan oxygenase (TO) and p450s, which are expressed in the adult liver (Kamiya et al., 2002) . These in vitro culture systems provide a means to analyze the function of genes essential for mouse development, defects of which result in embryonic lethality.
In this paper, we found that the number of hepatocytes in jmj 2 /jmj 2 mice was markedly reduced in comparison with control mice. The expression of jmj in the hepatocytes was increased during development. We employed an in vitro culture system to analyze the proliferation and differentiation of hepatocytes in jmj 2 /jmj 2 embryos. Interestingly, the proliferation potential of jmj 2 /jmj 2 hepatocytes was comparable to the wild-type cells in vitro, however, maturation of the hepatocytes was severely impaired by the jmj gene inactivation. These results suggested that jmj plays a pivotal role in the development of the mid-fetal liver to the neonatal liver.
Results

Hepatic hypoplasia in jmj
2 /jmj 2 embryos
As previously described (Motoyama et al., 1997) , the liver in jmj 2 /jmj 2 embryos at E14.5 was smaller than wild type ( jmj þ /jmj þ ) and heterozygous type ( jmj þ /jmj 2 ) liver (Fig. 1A) , while no significant difference in size and morphology was apparent between mutant and wild type in E11.5. We examined the number of cells expressing alpha-1-fetoprotein (AFP), a specific marker for immature fetal hepatocytes (Fig. 1B, C, F) . Staining of cell smears from fetal livers with antibody against AFP showed that the total number of AFP þ hepatocytes in the fetal liver of jmj 2 /jmj 2 embryos was comparable to those of heterozygous and wild type embryos at E11.5. In contrast, at E12.5, E13.5 and E14.5, the numbers of AFP þ hepatocytes in jmj 2 /jmj 2 embryos were approximately 40% to 50% of those in heterozygous and wild type embryos. We also compared the number of hepatocytes in the fetal liver at E13.5 and E14.5, using antibody against albumin, a marker of hepatocytes ( Fig. 1D , E, G). The number of albumin þ hepatocytes in the jmj 2 /jmj 2 liver was about 40% of heterozygous and wild type embryos at E13.5 and E14.5. These results indicate that the absolute number of hepatocytes is decreased in the jmj 2 /jmj 2 fetal liver.
Expression of jmj in the liver during development
In the fetal liver, the jmj gene was previously shown to be expressed in megakaryocytes, endothelial cells, fibroblastic cells and unknown hematopoietic cells, but not in hepatocytes (Motoyama et al., 1997) . However, as the developmental change of jmj expression in the liver after E14.5 was not known, we examined the jmj expression during fetal liver development using liver sections (Fig. 2) . As the lacZ gene is inserted in the jmj gene in mutant mice, b-galactosidase activity can be used to monitor the expression of jmj in heterozygous ( jmj þ /jmj 2 ) mice (Takeuchi et al., 1995; Motoyama et al., 1997) . Because the lacZ gene used for the gene trap contains the nuclear localization signal, b-galactosidase is localized to the nucleus (Takeuchi et al., 1995) . Sections of the jmj þ / jmj 2 livers were stained with X-gal and anti-albumin antibody. As previously described, the jmj gene was expressed in endothelial cells that cover the inner surface of the blood vessels and megakaryocytes at E14.5 and E16.5 ( Fig. 2A, B) . However, weak expression of jmj was detected in albumin þ hepatocytes at E18.5 ( Fig. 2C ) and the expression further increased gradually from the neonate to adult stage ( Fig. 2D -G) .
is another b-galactosidase substrate and is much more sensitive than X-gal staining (Nolan et al., 1988) . To determine whether or not jmj was expressed at an earlier stage of hepatocytes, we performed FDG staining of Dlk þ cells. We recently found that Dlk, a cell surface molecule with EGF-repeats (Laborda et al., 1993) , is highly expressed in immature hepatocytes and that Dlk þ cells isolated by anti-Dlk antibody from fetal liver proliferate and differentiate to hepatocytes in vitro and in vivo (Tanimizu et al., 2003) . We isolated Dlk þ cells from
2 and found that a significant fraction of Dlk þ hepatocytes in jmj þ /jmj 2 at E14.5 exhibited b-galactosidase activity (Fig. 2I) . Thus, the expression of jmj in immature hepatocytes starts around E14.5 and increases along with hepatic development. 12.5, 13.5 and 14.5 used were jmj þ /jmj þ (n ¼ 4, 7, 7 and 5), jmj þ /jmj 2 (n ¼ 7, 9, 7 and 5) and jmj 2 /jmj 2 (n ¼ 4, 6, 7 and 3). (G) The numbers of albumin þ hepatocytes in a fetal liver at E13.5 and E14.5. The numbers of embryos at E13.5 and 14.5 used were jmj þ /jmj þ (n ¼ 7 and 5), jmj þ /jmj 2 (n ¼ 7 and 5) and
( ) and jmj 2 /jmj 2 ( ) mice are shown as mean^SEM.
Expression of jmj in a primary culture system
The expression of jmj after the mid-fetal stage in hepatocytes suggested the possibility that jmj is involved in hepatic development. However, as jmj 2 /jmj 2 embryos were lethal at around E15.5 (Motoyama et al., 1997) , it was not possible to analyze the development of jmj 2 /jmj 2 hepatocytes after the mid-fetal stage in vivo. Therefore, in order to study the functions of jmj in hepatic development, we employed a primary culture system of E14.5 fetal hepatocytes. In this system, differentiation of fetal hepatocytes can be induced by OSM Kinoshita et al., 1999) . First, we examined the expression of jmj in our culture system. Primary hepatic cells derived from E14.5 jmj þ /jmj 2 embryos were stained with X-gal and anti-albumin antibody. A strong signal in the nucleus was observed in megakaryocytes and some hematopoietic cells at 0 and 1 day in culture, whereas the jmj expression was not detected in albumin þ hepatocytes (Fig. 3A, B ). However, a weak expression of the jmj gene was observed in hepatocytes after 2 days of culture with OSM ( Fig. 3C) , and the expression significantly increased from day 3 to 5 in culture ( Fig. 3D, E ). There was no further increase in the jmj expression from day 5 to 7. In this primary culture, hepatocytes start expressing G6Pase and TAT, perinatalspecific liver enzymes, after 4 days of culture . These results suggest that jmj is expressed in our primary culture in a manner similar to embryonic development in vivo. 
Proliferation potential of jmj
2 /jmj 2 hepatocytes
The reduction of hepatocytes in jmj 2 /jmj 2 embryos and also the expression of jmj in hepatocytes suggested that the growth potential of the hepatocytes might be impaired. To test this possibility, we examined the proliferation of jmj 2 /jmj 2 hepatocytes in our primary culture system by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay (Fig. 4A, B) . In order to isolate hepatocytes from fetal livers, we employed anti-Dlk antibody (Tanimizu et al., 2003) . Dlk þ cells sorted by AutoMACS were cultured in a 96-well plate in the presence of Dex and OSM with 10% FCS, and the proliferation was assessed after 2 days of culture by the reduction of MTT. In the presence of 10% FCS, no significant difference was found in OD values between jmj 2 /jmj 2 , jmj þ /jmj þ and jmj þ /jmj 2 hepatocytes at E12.5 and E14.5. In addition, we evaluated DNA synthesis by using 5-bromo-2 0 -deoxyuridine (BrdU) (Fig. 4C) The expression of jmj in hepatocytes after the midfetal stage suggested that jmj is likely to be involved in fetal hepatic differentiation. We thus examined the functions of jmj in hepatic development using our primary culture system Kinoshita et al., 1999) . Dissociated fetal liver cells from individual embryos obtained by mating between heterozygous ( jmj þ /jmj 2 ) mice were cultured in the presence of Dex, OSM and EHS (extracellular matrices derived from Engelbreth-Holm-Swarm cells), a condition that induces hepatic maturation (Kamiya et al., 2002) . The expression of liver enzymes such as TAT, G6Pase, phosphoenolpyruvate carboxykinase (PEPCK) and tryptophan oxygenase (TO) was detected by Northern blot analysis. As previously described, OSM and EHS induced the expression of these genes in fetal hepatic culture derived from jmj þ /jmj þ and jmj þ /jmj 2 embryos. In contrast, the expression of liver-specific genes except for albumin in jmj 2 /jmj 2 hepatic culture was significantly reduced even in the presence of OSM and EHS (Fig. 5A, B) .
Although the vast majority of the cells in our culture system were hepatocytes, non-parenchymal cells were also included. Therefore, it remained unknown whether the defect in hepatic maturation in the primary culture derived from jmj 2 /jmj 2 mice was intrinsic to hepatocytes or in non-parenchymal cells. We thus examined the expression of liver enzymes in the primary culture of Dlk þ hepatocytes devoid of most non-parenchymal cells. Dlk þ cells were sorted from E14.5 fetal livers and cultured in the presence or absence of OSM and EHS. Consistent with the above results, Dlk þ hepatocytes derived from jmj þ /jmj þ embryos expressed marker genes of liver development when cultured with OSM and EHS. In contrast, the lack of jmj significantly suppressed the expression of those genes induced by OSM and EHS in the culture of Dlk þ hepatocytes (Fig. 6A, B) . These results indicate that the jmj expression in hepatocytes is necessary for the maturation of fetal hepatocytes. In addition, we examined whether the expression of hepatic marker genes in Dlk þ jmj 2 /jmj 2 hepatocytes was affected by wild-type Dlk 2 non-parenchymal cells. Dlk þ cells derived from jmj 2 /jmj 2 embryos were co-cultured with Dlk 2 cells derived from jmj þ /jmj þ embryos in the presence of Dex, OSM and EHS, however, the expression of hepatic marker genes in Dlk þ cells was not up-regulated by coculture with Dlk 2 non-parenchymal cells (Fig. 6C) (Fig. 6D) . These results collectively indicate that the defective differentiation of jmj 2 /jmj 2 hepatocytes after E12.5 is cell autonomous. 
Discussion
The jmj gene was previously shown to be expressed in megakaryocytes, endothelial cells, fibroblastic cells and unknown hematopoietic cells, but not in hepatocytes in the mid-fetal stage liver (Motoyama et al., 1997) . However, we found that jmj was very weakly expressed in hepatocytes at the mid-fetal stage and significantly increased from E18.5 to adult along with liver development (Fig. 2) . By using a primary culture of fetal hepatocytes of jmj þ /jmj 2 embryos, we found that E14.5 immature hepatocytes slightly expressed jmj for the first 2 days of culture and the expression was significantly upregulated thereafter ( fig. 3) , consistent with the jmj expression in fetal liver development in vivo. During the perinatal stage when the jmj expression increases, the fetal liver dramatically increases its size and acquires numerous metabolic functions (Zaret, 1998) . These results suggest that jmj may play a role for the proliferation and differentiation of hepatocytes. However, the jmj 2 /jmj 2 embryos displayed severe hypoplasia of the fetal liver before E14.5, while immature hepatocytes expressed jmj very weakly at this stage. Therefore, the abnormality of the jmj 2 /jmj 2 fetal liver at an early embryonic stage is likely due to an environmental defect.
The number of AFP þ hepatocytes in the jmj 2 /jmj 2 fetal liver was about half of that in the control at E12.5, E13.5 and E14.5, whereas the number of AFP þ hepatocytes from the jmj 2 /jmj 2 fetal liver was almost the same as that of control at E11.5 (Fig. 1F) . Moreover, the number of albumin þ hepatocytes in the fetal liver of jmj 2 /jmj 2 at E13.5 and E14.5 was also reduced to about 40% of the control mice (Fig. 1G ), while no difference was found in size and gross morphology among jmj þ /jmj þ , jmj þ /jmj 2 and jmj 2 /jmj 2 livers at E11.5. We also observed that the liver weight at E14.5 was reduced in jmj 2 /jmj 2 embryos (Fig. 1A) . These results strongly suggest that the proliferation of hepatocytes, but not non-parenchymal cells, is severely impaired after E12.5. In addition, the proliferation of hepatocytes measured by the MTT assay and BrdU incorporation showed that jmj 2 /jmj 2 hepatocytes at E12.5 and E14.5 proliferated equally well as the jmj þ /jmj þ hepatocytes in the primary culture system (Fig. 4) . These results indicate that defective proliferation of hepatocytes in jmj 2 /jmj 2 embryos after E12.5 is not cell autonomous and is probably due to a defect in their environment. At around E11.5, hematopoietic stem cells and progenitors in the AGM region and the yolk sac colonize the fetal liver (Müller et al., 1994; Medvinsky and Dzierzak, 1996) . Our previous results suggest that hematopoietic cells expanding in the fetal liver produce cytokines such as Oncostatin M, which induce hepatic development . We found that the number of AFP þ hepatocytes was reduced in the jmj 2 / jmj 2 fetal liver after E12.5 (Fig. 1F ) and that jmj expression was detected in the jmj þ /jmj 2 AGM region (data not shown). Thus, one possibility is that the migration of hematopoietic cells from the AGM region to the liver is perturbed in jmj 2 /jmj 2 embryos, resulting in defective liver development. As jmj is expressed in endothelial cells in the fetal liver (Fig. 2) , another possibility is that the loss of jmj expression in the endothelial cells may result in the defective proliferation of hepatocytes. This is an interesting possibility because a recent report indicates that endothelial cells play a key role in proliferation of hepatoblasts in the liver bud (Matsumoto et al., 2001) . It is thus possible that the liver bud developed from the jmj 2 /jmj 2 foregut endoderm has a defect, leading to the decreased proliferation of hepatocytes at a later stage. However, as we found that Dlk hepatocytes isolated from E12.5 and E14.5 jmj 2 /jmj 2 livers proliferated normally in vitro (Fig. 4) , it is likely that hepatocytes at these stages no longer require non-parenchymal cells such as hematopoietic cells and endothelial cells. While the proliferation potential was almost unchanged in jmj 2 /jmj 2 hepatocytes as described above, the differentiation potential was significantly affected by jmj. The induction of liver enzyme genes expressed in the adult liver was dramatically reduced in the primary culture of jmj 2 / jmj 2 hepatocytes (Fig. 5) and accumulation of intracellular glycogen was also reduced in cultured jmj 2 /jmj 2 hepatocytes (data not shown). In addition, hepatocytes purified using anti-Dlk antibody (Tanimizu et al., 2003) also exhibited defective maturation in the absence of jmj and co-culture of Dlk þ jmj 2 /jmj 2 hepatocytes with Dlk 2 wildtype liver cells failed to recover the hepatic maturation (Fig. 6) . These results together with the expression of jmj in hepatocytes at a later gestation stage indicate that the expression of jmj in hepatocytes is required for hepatic maturation.
In addition to defects in hepatocyte differentiation, the jmj mutant embryos show several proliferation abnormalities, for example, hyperplasia of cardiac myocytes and an increase in the population of megakaryocytes in the fetal liver (Motoyama et al., 1997) . Overexpression of jmj cDNA in COS-7 and NIH-3T3 cells results in a remarkable reduction of cell proliferation and DNA synthesis (Toyoda et al., 2000) . These data suggest that jmj acts as a negative regulator of cell proliferation (Toyoda et al., 2000) . It remains to be studied how such activity of jmj is coupled to the maturation of hepatocytes. As jmj protein has a domain homologous to Fig. 6 DNA-binding domains (Takeuchi, 1997; Balciunas and Ronne, 2000) and is localized to the nucleus (Toyoda et al., 2000) , jmj may function as a transcription factor.
Experimental procedures
Mice
The jmj 2 /jmj 2 embryos were obtained by intercrossing F23-32 jmj þ /jmj 2 mice with the BALB/cA genetic background (Takeuchi et al., 1995) . The genotype of embryos was determined by X-gal staining (Boehringer Mannheim) of tail snips of embryos and was confirmed by PCR using genomic DNA isolated from a limb (Takeuchi et al., 1995) .
Media and cell culture
Dulbecco's modified Eagle's medium (DMEM), fetal calf serum (FCS), liver perfusion medium, liver digest medium, minimal essential medium (MEM) non-essential amino acid solution, gentamicin, L-glutamine and insulin-transferrin-selenium X (ITS) were purchased from Gibco-BRL.
Fetal livers were minced and incubated in liver perfusion medium and dissociated with liver digest medium. The dissociated cells were hemolysed with hypotonic buffer. Single cells were suspended in culture medium composed of Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FCS, 2 mM L-glutamine, 1 £ non-essential amino acid solution, 1 £ insulin-transferrinselenium X, 50 mg/ml gentamicin and 10 27 M dexamethasone (Dex) and plated onto 0.1% gelatin-coated Primaria cell culture dishes. Several hours later, floating hematopoietic cells and cell debris were removed by washing with PBS supplemented with 5% FCS. Cells were cultured with fresh medium containing Dex with or without 10 ng/ml OSM. Culture medium and cytokines were replaced every other day. EHS gel was added to the medium on day 5 of culture if necessary. Dlk þ cell culture was prepared as follows. Dissociated liver cells were stained with hamster anti-mouse Dlk antibody (provided by KIRIN Brewery) (Kaneta et al., 2000) and washed with PBS containing 5% FCS. Cells were then stained with biotinylated anti-hamster IgG (Vector Laboratories) followed by incubation with streptavidin-coated MicroBeads (Miltenyi Biotec GmbH). Dlk þ cells were then sorted by Auto MACS (Miltenyi Biotec GmbH). The purity of sorted Dlk þ cell fractions was more than 90%.
X-gal staining and immunohistochemistry
Embryos and adult livers were fixed in 1% formaldehyde, 0.2% glutaraldehyde and 0.02% NP-40 in PBS at 4 8C for 2 h. They were then placed in 30% sucrose at 4 8C and embedded in OTC compound (Sakura). The frozen sections were stained overnight at room temperature in 0.1% X-gal (Boehringer Mannheim), 5 mM K 4 Fe(CN) 6 and 5 mM K 3 Fe(CN) 6 in PBS. Sections were washed in PBS and fixed in 4% paraformaldehyde in PBS and processed for immunohistochemistry as described below.
For fluorescein di-b-D-galactopyranoside (FDG) loading, Dlk þ cells sorted by Auto MACS were resuspended in 50 ml of staining medium (PBS supplemented with 4% FCS, 10 mM HEPES) prior to loading with 50 ml of 2 mM FDG (Molecular Probes) in sterile water followed by incubation at 37 8C for one minute. The FDG incorporation was stopped by the addition of 1 ml of ice-cold staining medium. To confirm the expression of Dlk, allophycocyanin (APC)-conjugated streptavidin was added to stain the cells that bound anti-Dlk antibody and fluorescence was detected by FACSCalibur (Becton -Dickinson).
For immunohistochemistry, the frozen sections were incubated with rabbit polyclonal anti-mouse albumin (Nordic Immunological Laboratories) antibodies and stained with the Vectastain ABC Elite kit (Vector Laboratories). Fetal liver cells prepared by enzyme-based liver digest medium were placed on glass slides by centrifugation using a Cytospin-3 (Shandon), and stained with rabbit anti-human alpha-1-fetoprotein (AFP, ICN) or anti-albumin antibody and hematoxylin (Muto Pure Chemicals Ltd.). More than 1000 cells were counted in each sample. The number of AFP þ cells or albumin þ cells per fetal liver was estimated by the percentage of AFP þ cells or albumin þ cells in the samples.
Cell proliferation assay
Dlk þ cells were suspended in culture medium composed of DMEM supplemented with 10% FCS, 2 mM L-glutamine, 1 £ non-essential amino acid solution, 1 £ ITS, 50 mg/ml gentamicin and 10 27 M Dex with or without 10 ng/ml OSM and 5 £ 10 3 Dlk þ cells plated onto a 0.1% gelatin-coated 96-well plate. To analysis cell proliferation activity, we used 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay. After 2 days of culture, the cells were incubated with 500 mg/ml MTT (Dojindo Laboratories) in PBS for 4 h. Subsequently, 0.04 N HCl in isopropanol was added to the cells, and then mixed thoroughly to dissolve the dark blue crystals, and the optical density was measured at 570 nm.
We also employed BrdU incorporation to monitor cell proliferation by using the Cell Proliferation kit (Amersham Bioscience). Dlk þ cells (2 £ 10 4 ) plated on 8 well Lab-Tek Chamber Slides coated with 0.1% gelatin (Nalge Nunc International). After 2 days of culture, the cells were labeling with 3 mg/ml of 5-bromo-2 0 -deoxyuridine (BrdU) for 2 h. After fixation with 3.7% formaldehyde in PBS, the cells were incubated with mouse anti-BrdU antibody in nuclease. Subsequently, the cells were incubated with biotin-conjugated goat anti-mouse IgG (g) (Caltag Laboratories) and the Vectastain ABC Elite kit. Finally, cells were counterstained with hematoxylin (Wako Pure Chemical Industries, Ltd.). BrdU positive cells in the total nucleated cells were counted.
Northern blot analysis
Total RNA was isolated using TRIZOL reagent (Gibco-BRL) according to the supplier's protocol. Nine micrograms of total RNA from each sample was separated by electrophoresis on 1% agarose gels containing 6.7% formaldehyde and transferred to a positively charged nylon membrane (Boehringer Mannheim). The membrane was hybridized with digoxigenin (DIG)-labeled cDNA probes and treated with alkaline phosphatase-labeled anti-DIG antibody (Boehringer Mannheim). The blot was developed with CDP-star reagent (New England Biolabs).
NIH Image 1.62 (National Institute of Health) was used to measure densities of bands in Northern blot. Density of each band was normalized by the GAPDH band intensity in the same sample.
